{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T10:11:10Z","timestamp":1744279870452},"reference-count":34,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.vaccine.2007.10.013","type":"journal-article","created":{"date-parts":[[2007,10,26]],"date-time":"2007-10-26T09:58:26Z","timestamp":1193392706000},"page":"8487-8499","source":"Crossref","is-referenced-by-count":43,"title":["A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants"],"prefix":"10.1016","volume":"25","author":[{"given":"Terry","family":"Nolan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Don","family":"Roberton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Richmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Streeton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Poolman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Boutriau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2007.10.013_bib1","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1086\/315158","article-title":"The changing epidemiology of meningococcal disease in the United States, 1992\u20131996","volume":"180","author":"Rosenstein","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.10.013_bib2","first-page":"333","article-title":"Meningococcal disease and vaccination in North America","volume":"55","author":"Pollard","year":"2004","journal-title":"Annu Rev Med"},{"issue":"18","key":"10.1016\/j.vaccine.2007.10.013_bib3","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","article-title":"Meningococcal disease","volume":"344","author":"Rosenstein","year":"2001","journal-title":"N Engl J Med"},{"issue":"31","key":"10.1016\/j.vaccine.2007.10.013_bib4","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1016\/S0264-410X(01)00209-2","article-title":"Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States","volume":"19","author":"Lingappa","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.10.013_bib5","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1542\/peds.2006-0281","article-title":"Multicenter surveillance of invasive meningococcal infections in children","volume":"118","author":"Kaplan","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2007.10.013_bib6","doi-asserted-by":"crossref","first-page":"S274","DOI":"10.1097\/01.inf.0000147642.85129.05","article-title":"Global epidemiology of meningococcal disease and vaccine efficacy","volume":"23","author":"Pollard","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.vaccine.2007.10.013_bib7","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1586\/14760584.5.4.445","article-title":"Experience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135","volume":"5","author":"Keyserling","year":"2006","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2007.10.013_bib8","unstructured":"Pediarix\u2122 Summary of Product Characteristics."},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.013_bib9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2007.10.013_bib10","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/JCM.32.6.1475-1482.1994","article-title":"Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay","volume":"32","author":"Gheesling","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2007.10.013_bib11","unstructured":"World Health Organization. Guidelines for WHO\/EPI Collaborative Studies on Poliomyelitis-Standard Procedure for Determining Immunity to Poliovirus using the Microneutralization Test 1993:1\u201326 (http:\/\/www.who.int: WHO\/EPI\/GEN 1993.09, (1139):1\u201326)."},{"key":"10.1016\/j.vaccine.2007.10.013_bib12","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1128\/CDLI.8.2.266-272.2001","article-title":"Pneumococcal type 22F polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay","volume":"8","author":"Concepcion","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2007.10.013_bib13","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/CDLI.2.5.590-597.1995","article-title":"Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S","volume":"2","author":"Quataert","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.10.013_bib14","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from post-licensure surveillance in England","volume":"10","author":"Andrews","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2007.10.013_bib15","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/IAI.69.3.1568-1573.2001","article-title":"Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection","volume":"69","author":"Borrow","year":"2001","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2007.10.013_bib16","first-page":"149","article-title":"Serologic response to serogroup C meningococcal vaccine in Brazilian preschool children","volume":"16","author":"Amato Neto","year":"1974","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.vaccine.2007.10.013_bib17","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/CVI.13.3.356-360.2006","article-title":"Critical differences between pneumococcal polysaccharide enzyme-linked immunosorbent assays with and without 22F inhibition at low antibody concentrations in pediatric sera","volume":"13","author":"Henckaerts","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"December (9195)","key":"10.1016\/j.vaccine.2007.10.013_bib18","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(99)04377-9","article-title":"Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis","volume":"354","author":"Eskola","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.10.013_bib19","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/infdis\/147.6.1100","article-title":"The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b","volume":"147","author":"K\u00e4yhty","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.10.013_bib20","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/infdis\/149.6.1034","article-title":"The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b","volume":"149","author":"Anderson","year":"1984","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.10.013_bib21","unstructured":"Centers for Disease Control and Prevention (CDC). Progress toward elimination of Haemophilus influenzae type b disease among infants and children\u2014United States, 1987\u20131995. MMWR Morb Mortal Wkly Rep. 1996;45(42):901\u20136."},{"issue":"February (7385)","key":"10.1016\/j.vaccine.2007.10.013_bib22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bmj.326.7385.365","article-title":"Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis","volume":"326","author":"Ramsay","year":"2003","journal-title":"BMJ"},{"issue":"October (Suppl. 1)","key":"10.1016\/j.vaccine.2007.10.013_bib23","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0264-410X(01)00299-7","article-title":"Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story","volume":"20","author":"Miller","year":"2001","journal-title":"Vaccine"},{"issue":"9431","key":"10.1016\/j.vaccine.2007.10.013_bib24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction","volume":"364","author":"Trotter","year":"2004","journal-title":"Lancet"},{"issue":"9355","key":"10.1016\/j.vaccine.2007.10.013_bib25","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0140-6736(03)12441-5","article-title":"Conjugate Hib vaccines","volume":"361","author":"Steinhoff","year":"2003","journal-title":"Lancet"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2007.10.013_bib26","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1128\/IAI.66.5.2093-2098.1998","article-title":"Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants","volume":"66","author":"Dagan","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.10.013_bib27","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/S0140-6736(97)07456-4","article-title":"Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens","volume":"351","author":"Lagos","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.10.013_bib28","unstructured":"Gatchalian S, Pama CL, Palestroque E, De Vleeschauwer I, Han HH, Poolman J, Schuerman L, et al. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components. IJID, in press."},{"key":"10.1016\/j.vaccine.2007.10.013_bib29","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1128\/CVI.00377-06","article-title":"Immunogenicity, reactogenicity and immune memory after primary vaccination with a novel Haemophilus influenzae-Neisseria meningitidis serogroup C conjugate vaccine","volume":"14","author":"Schmitt","year":"2007","journal-title":"Clin Vaccine Immun"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2007.10.013_bib30","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1128\/IAI.69.4.2378-2382.2001","article-title":"Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus-toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains","volume":"69","author":"Richmond","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.10.013_bib31","unstructured":"Pediacel\u2122 Summary of Product Characteristics."},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.013_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/adc.2005.076109","article-title":"Evaluation of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b vaccine given concurrently with meningococcal group C conjugate vaccine at 2, 3 and 4 months of age","volume":"92","author":"Kitchin","year":"2007","journal-title":"Arch Dis Child"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2007.10.013_bib33","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1128\/IAI.72.9.5383-5391.2004","article-title":"Reduction of antibody response to an 11-valent pneumococcal vaccine co-administered with a vaccine containing acellular pertussis components","volume":"72","author":"Dagan","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.10.013_bib34","series-title":"15th International Pathogenic Neisseria Conference (IPNC)","article-title":"Immunogenicity and reactogenicity of a combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C and Y-tetanus-toxoid conjugate (Hib-MenCY-TT) vaccine administered at 2, 3 and 4 months and as a booster dose at second year of life","author":"Habermehl","year":"2006"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07011553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07011553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T07:48:26Z","timestamp":1629964106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07011553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":34,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0264410X07011553"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.10.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}